Company profile for Selvita S.A

Selvita S.A

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-2-2026-02-09

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

17 News #PharmaBuzz

media
17 News #PharmaBuzz

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Selvita Group is an integrated drug discovery services provider from Krakow, Poland. It offers its clients drug discovery support at every stage of the early discovery phase up to preclinical research. We provide services ranging from computational chemistry and in silico drug design, through hit to lead optimisation, chemical development and custom synthesis. In addition, Selvita offers a wide range of preclinical in vitro se...

Selvita Group is an integrated drug discovery services provider from Krakow, Poland. It offers its clients drug discovery support at every stage of the early discovery phase up to preclinical research. We provide services ranging from computational chemistry and in silico drug design, through hit to lead optimisation, chemical development and custom synthesis. In addition, Selvita offers a wide range of preclinical in vitro services focusing on identification and confirmation of mechanism of action as well as ADME-Toxicity studies.

Natural Products ExpoNatural Products Expo

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A
Pharma & Device Packag...Pharma & Device Packaging

Not Confirmed

Not Confirmed

04-05 March, 2026

California, U.S.A
PPL USPPL US

Not Confirmed

Not Confirmed

04-05 March, 2026

California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

Country

Poland

Address

Address

Selvita S.A.Park Life Scienceul. Bobrzyńskiego 14,30-348 Kraków

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

http://selvita.com/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Selvita Strengthens Sales & Drug Development Management

10 Dec 2024

// PR NEWSWIRE

Selvita Reports Strong H2 2024 Recovery, Sees Promising Outlook

21 Nov 2024

// PR NEWSWIRE

Selvita Reports Growing Sales Projects Higher H2 Profitability

24 Sep 2024

// PR NEWSWIRE

Selvita Expands Capabilities With PozLab Acquisition

07 May 2024

// PR NEWSWIRE

Selvita launches biologic drug discovery and development services

18 Mar 2024

// PR NEWSWIRE

Selvita Q1 2023 financial results exceed initial estimates

31 May 2023

// PR NEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search